[go: up one dir, main page]

AU3528499A - Use of compounds for reducing apoptosis - Google Patents

Use of compounds for reducing apoptosis

Info

Publication number
AU3528499A
AU3528499A AU35284/99A AU3528499A AU3528499A AU 3528499 A AU3528499 A AU 3528499A AU 35284/99 A AU35284/99 A AU 35284/99A AU 3528499 A AU3528499 A AU 3528499A AU 3528499 A AU3528499 A AU 3528499A
Authority
AU
Australia
Prior art keywords
compounds
reducing apoptosis
apoptosis
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35284/99A
Inventor
Francoise Bono Colombie
Pierre Casellas
Jean-Marc Herbert
Gerard Lefur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority claimed from PCT/FR1999/001069 external-priority patent/WO1999058117A1/en
Publication of AU3528499A publication Critical patent/AU3528499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU35284/99A 1998-05-13 1999-05-06 Use of compounds for reducing apoptosis Abandoned AU3528499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9806081 1998-05-13
FR9806081A FR2778564B1 (en) 1998-05-13 1998-05-13 USE OF COMPOUNDS REDUCING APOPTOSIS
PCT/FR1999/001069 WO1999058117A1 (en) 1998-05-13 1999-05-06 Use of compounds for reducing apoptosis

Publications (1)

Publication Number Publication Date
AU3528499A true AU3528499A (en) 1999-11-29

Family

ID=9526343

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35284/99A Abandoned AU3528499A (en) 1998-05-13 1999-05-06 Use of compounds for reducing apoptosis

Country Status (2)

Country Link
AU (1) AU3528499A (en)
FR (1) FR2778564B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894478B1 (en) * 2005-12-08 2008-06-06 Anticiper Et Developper L Inno APPLICATION OF ISOQUINOLINE CARBOXAMIDE AND ITS DERIVATIVES AS BACTERIAL VIRULENCE INHIBITORS AS REPLACEMENT OR COMPLEMENT TO CLASSIC ANTIBIOTICS
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58167514A (en) * 1982-03-26 1983-10-03 Itaru Yamamoto Immunological regulating agent
FR2525595A1 (en) * 1982-04-27 1983-10-28 Pharmuka Lab NOVEL ARENE AND HETEROARENECARBOXAMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS
FR2538388B1 (en) * 1982-12-24 1985-06-21 Pharmuka Lab NOVEL NAPHTHALENE- OR AZANAPHTHALENECARBOXAMIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
DE3435974A1 (en) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim PHARMACEUTICAL COMPOSITIONS CONTAINING DIAZEPINE WITH PAF-ANTAGONISTIC EFFECT
FR2582514B1 (en) * 1985-05-30 1988-02-19 Rhone Poulenc Sante AMIDE DRUGS, NEW AMIDES AND THEIR PREPARATION
FR2599740B1 (en) * 1986-06-05 1988-08-12 Rhone Poulenc Sante BENZO (B) THIOPHENE DERIVATIVES OF BENZO (B) FURANNECARBOXAMIDES, PROCESSES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM
US4898861A (en) * 1987-03-26 1990-02-06 Hoffmann-La Roche Inc. Method for inhibiting the proliferation of tumor cells
FR2615513B1 (en) * 1987-05-21 1989-07-13 Synthelabo DERIVATIVES OF ACYLAMINOMETHYL-3 TETRAHYDRO-5,6,7,8 IMIDAZO (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DK273689A (en) * 1988-06-06 1989-12-07 Sanofi Sa 4-AMINO-3-CARBOXYQUINOLINES AND -NAPHTHYRIDINES, PROCEDURES FOR THEIR PREPARATION AND USE OF THEM IN PHARMACEUTICALS
FR2659329B1 (en) * 1990-03-09 1994-06-03 Adir NOVEL IMIDAZO [1,2-C] QUINAZOLINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2660310B1 (en) * 1990-03-27 1992-06-05 Adir NOVEL 4H-PYRROLO [1,2A] THIENO [2,3-F] DIAZEPINE [1,4] DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5091381A (en) * 1991-04-12 1992-02-25 Biomeasure, Inc. 2H-1,3,4-benzotriazepin-2-ones
EP0524846A1 (en) * 1991-06-27 1993-01-27 Synthelabo 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics
US5206382A (en) * 1991-06-27 1993-04-27 Fidia Georgetown Institute For The Neurosciences Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
FR2678269B1 (en) * 1991-06-27 1995-01-13 Synthelabo DERIVATIVES OF 1- (4-CHLOROPHENYL) -2- [4- (2-PHENYLETHYL) PIPERIDIN-1-YL] ETHANOL, THEIR APPLICATION AND THEIR PREPARATION IN THERAPEUTICS.
US5550124A (en) * 1991-12-10 1996-08-27 University Of Southern California Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease
FR2727864B1 (en) * 1994-12-12 1997-04-04 Synthelabo USE OF LIGANDS FROM THE PERIPHERAL BINDING SITES FOR BENZODIAZEPINES FOR THE PREPARATION OF DRUGS USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES
IL117659A (en) * 1995-04-13 2000-12-06 Dainippon Pharmaceutical Co Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
US5776946A (en) * 1995-08-28 1998-07-07 Mcgeer; Patrick L. Peripheral benzodiazepine receptor ligands as antiinflammatory agents
AU727482B2 (en) * 1996-10-01 2000-12-14 Daiichi Pharmaceutical Co., Ltd. Mitochondrial membrane stabilizer

Also Published As

Publication number Publication date
FR2778564B1 (en) 2001-07-13
FR2778564A1 (en) 1999-11-19

Similar Documents

Publication Publication Date Title
AU2863899A (en) New compounds
AU4580599A (en) Stable no-delivering compounds
AU5100599A (en) Egf-genistein for prevention of restenosis
AU4260199A (en) Novel compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU5980899A (en) Novel compounds
AU4567199A (en) Autoinducer compounds
AUPQ137699A0 (en) Control of acidosis
AU6143998A (en) Regulators of apoptosis
AU4030399A (en) Bicyclic compounds having an anti-thrombitic effect
AU1434500A (en) Compounds
AU3637699A (en) Preparation of carbocyclic compounds
AU4814699A (en) Novel compounds
AU5446499A (en) Apoptosis inducing agents
AU3454799A (en) Regulated apoptosis using chemically induced dimerization of apoptosis factors
AU3528499A (en) Use of compounds for reducing apoptosis
AU5622599A (en) Use of 5-amino-pyrazol-derivatives for combating micro-organisms
AU2001275063A1 (en) Regulators of apoptosis
AU1682400A (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU2863799A (en) New compounds
AU1479600A (en) Anti-icam-r antibody-induced apoptosis
AU2725599A (en) Substituted alxoxycarbonyl compounds
AU3679800A (en) Apoptosis inhibitors
AU2392600A (en) Synthesis of bisphenols

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL14, NO113(PATENT GAZETTE 20000504) UNDER THE HEADING "APPLICATION LAPSED, REFUSED OR WITHDRAWN" DELETE ALL REFERENCE TO THIS APPLICATION

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase